RIM9 operates within the Rim pathway, a conserved pH-sensing cascade critical for fungal adaptation to alkaline environments. Key steps include:
pH Sensing:
Signal Transduction:
Downstream Targets:
Disruption of RIM9 or other Rim proteins in C. albicans increases sensitivity to antifungals, suggesting conserved mechanisms in C. glabrata . Key findings include:
HSP90 and IPT1 (sphingolipid biosynthesis) are downstream targets of RIM101, linking pH adaptation to antifungal tolerance .
Pharmacological inhibition of HSP90 synergizes with Rim pathway disruption, highlighting potential therapeutic strategies .
C. glabrata exploits C. albicans hyphae for host colonization, mediated by pH-regulated adhesins (e.g., EPA8, AWP2) . While RIM9 itself is not directly implicated in this interaction, its role in regulating pH-responsive genes may indirectly influence biofilm formation and adhesion .
While RIM9 is conserved, structural differences (e.g., length) suggest species-specific adaptations .
Therapeutic Targeting: Inhibiting RIM9 or downstream targets (e.g., HSP90) may enhance antifungal efficacy .
Diagnostic Biomarkers: Recombinant RIM9 could aid in detecting C. glabrata infections or monitoring treatment responses .
Pathogenesis Studies: Investigating RIM9 in C. glabrata’s ability to colonize mucosal surfaces or evade host immunity.
Essential for the proteolytic cleavage of the transcription factor RIM101 in response to alkaline pH.
KEGG: cgr:CAGL0F06545g
STRING: 284593.XP_446252.1